Dementia Discovery Fund, backed by more than half a dozen corporates, reached its final close after AARP supplied $60m.

Amgen Ventures, Brace Pharma Capital and Alexandria Venture Investments all invested in the genome editing technology provider.

The ride services provider, which closed $1.5bn in funding earlier this year, is in talks with Tencent, Google and JD.com for more capital.

IP Group and Penn Medicine have both returned to back a series A round for Carisma Therapeutics, the Pennsylvania spinout formerly known as Carma.

ING Ventures led a round for the blockchain trading technology developer that included fellow corporates BNP Paribas and Tech Mahindra.

Existing backer Simon Ventures returned to back a series A round for curated fashion marketplace Grailed, taking its total funding to $20m.

Micro-infusion system developer Mercator MedSystems has received $11m in a round led by Salubris, which has licensed its technology in China.

Open innovation adviser China Materialia has received $5.9m from Henkel Ventures for its second venture capital fund.

The electronics maker took part in a round that increased the total raised by Intel-backed retail data provider Bossa Nova to $88m.

Email security software provider Agari, whose investors include Dell, increased its funding to $88m altogether with a Goldman Sachs-led round.